Annual report pursuant to Section 13 and 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
$ in Thousands
12 Months Ended
Nov. 30, 2018
Nov. 30, 2017
REVENUES $ 18,655 $ 10,089
COST OF REVENUES 10,824 6,807
GROSS PROFIT 7,831 3,282
RESEARCH AND DEVELOPMENT EXPENSES, net 6,464 2,478
AMORTIZATION OF INTANGIBLE ASSETS 1,913 1,631
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES 16,303 9,189
OTHER INCOME, net (2,930) 0
SHARE IN LOSSES OF ASSOCIATED COMPANY 731 1,214
OPERATING LOSS 14,650 11,230
FINANCIAL EXPENSES, net 3,117 2,447
LOSS BEFORE INCOME TAXES 17,767 13,677
TAX EXPENSES (INCOME) 1,337 (1,310)
NET LOSS 19,104 12,367
NET INCOME ATTRIBUTABLE TO NON- CONTROLLING INTERESTS (INCLUDING REDEEMABLE) (813) 0
NET LOSS ATTRIBUTABLE TO THE COMPANY $ 18,291 $ 12,367
NET LOSS ATTRIBUTABLE TO THE COMPANY LOSS PER SHARE:    
Basic $ 1.43 $ 1.28
Diluted $ 1.43 $ 1.31
WEIGHTED AVERAGE NUMBER OF SHARES USED IN COMPUTATION OF BASIC AND DILUTED LOSS PER SHARE:    
Basic 13,374,103 9,679,964
Diluted 13,374,103 9,714,252
COMPREHENSIVE LOSS -    
Net loss $ 19,104 $ 12,367
Other Comprehensive (income) loss - Translation adjustment 1,000 (2,630)
Comprehensive loss 20,104 9,737
Comprehensive income attributed to non-controlling interests (including redeemable) (813) 0
COMPREHENSIVE LOSS ATTRIBUTED TO ORGENESIS INC. $ 19,291 $ 9,737